Curation and Valuation
Identifying safer and more sustainable product ingredients which are both cost effective and easy to acquire can be a challenge within the consumer goods industry.
With the dramatic rise in antimicrobial resistance, companies are seeking to swap out compounds used in their products which are potential contributors to the rise of resistant bacteria.
Cataloguing all the appropriate data and identifying the right criteria for data validation are time consuming, resource heavy activities which often require specialist skills and can hamper enterprise organisations in the development of new and existing products.
A global consumer goods company was seeking to identify compounds which could provide a safer and more sustainable alternative to existing ingredients used in its household products.
However, the organisation not only needed to gather more relevant data to create an informed overview, but also needed to identify criteria which would enable selection of the most valuable data and in-turn reveal the relevant compounds.
This would then allow its researchers to carry out further analysis on compounds with a drastically improved chance of success.
The enterprise organisation approached Eagle Genomics for help. After reviewing the scope of the organisation’s current datasets, the Eagle team identified additional relevant open-source datasets which were then integrated with the institutional data to create the widest, richest and most informed data landscape possible.
Working closely with the global organisation, the Eagle team established customised data validation criteria including toxicity level, antimicrobial activity and availability of the compound.
The team was then able to design a conceptual data model, enabling analyses of the data to provide a table of potential compounds ranked according to the validation criteria.